Techno Trends
The most recent inventions, innovations, and ground-breaking technologies that are revolutionizing the healthcare landscape are presented to you in this section.
BrightHeart’s B-Right Views Receives FDA Clearance for CHD Detection
BrightHeart, a global provider of artificial intelligence (AI) solutions in obstetrics and paediatric cardiology, has received its third 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest innovation, B-Right Views. ...
BD Secures FDA Approval for First-of-Its-Kind Phasix™ ST Mesh for Umbilical Hernia Repair
BD (Becton, Dickinson and Company), a global leader in medical technology, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and announced the commercial launch of the Phasix™ ST Umbilical Hernia Patch. ...
CereVasc Received FDA Breakthrough Device Designation eShunt® System for Pediatric Patients
CereVasc, Inc., a clinical-stage medical device company focused on developing innovative treatments for neurological conditions, has received a second Breakthrough Device Designation from the US Food and Drug Administration (FDA)...
FDA Approves Navi Medical's First-of-its-Kind Neonav® ECG for Neonatal and Pediatric Care
Navi Medical Technologies has received 510(k) clearance from the U.S. Food and Drug Administration for its Neonav® ECG Tip Location System. The approval marks a major milestone in improving vascular access care for critically ill newborns and children....
FDA Grants Breakthrough Status to ICU Medical’s Plum Solo™ and Plum Duo™ Precision IV Pumps
ICU Medical Inc has received 510(k) clearance from the U.S. Food and Drug Administration for its new Plum Solo™ precision IV pump. This single-channel pump complements the previously cleared dual-channel Plum Duo...
Alpha Cognition Launches Breakthrough ZUNVEYL for Mild to Moderate Alzheimer’s
Alpha Cognition, a biopharmaceutical company focused on neurodegenerative diseases, has officially launched ZUNVEYL, a new treatment for individuals with mild to moderate Alzheimer’s disease. ...
Imfinzi Approved in EU as First Immunotherapy for Limited-Stage SCLC
AstraZeneca's Imfinzi (durvalumab) has received approval in the European Union (EU) for use as a monotherapy in adults with limited-stage small cell lung cancer (LS-SCLC). The treatment is specifically for patients whose disease has not progressed after undergoing platinum-based chemoradiation therapy (CRT)....
NEXTBIOMEDICAL Receives FDA Breakthrough Device Designation for Nexsphere-F™ Resorbable Microsphere
NEXTBIOMEDICAL has announced that its innovative product, Nexsphere-F™, has received Breakthrough Device Designation from the United States Food and Drug Administration (FDA). Nexsphere-F™ is a resorbable microsphere designed for musculoskeletal pain embolisation....
Stereotaxis Introduces First-of-its-Kind MAGiC Sweep™ a Robotically Navigated Mapping Catheter
Stereotaxis a leading company in surgical robotics for minimally invasive endovascular procedures, has submitted its MAGiC Sweep™ catheter for regulatory approval to the US Food and Drug Administration (FDA)....
Medtronic Receives First-of-Its-Kind Approval for BrainSense™ Adaptive DBS and Electrode Identifier
Medtronic has received FDA approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI), advancing personalised treatment for Parkinson’s disease. DBS, a key therapy for neurological disorders, has been enhanced with BrainSense...
